Simon Barry J. 4
4 · ImmunityBio, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Simon Barry J.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-01-31−57,200→ 0 total→ Common Stock (57,200 underlying) - Exercise/Conversion
Common Stock
2024-01-31+57,200→ 3,145,855 total - Tax Payment
Common Stock
2024-01-31$3.36/sh−22,094$74,236→ 3,123,761 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award vested on January 31, 2024.